383 related articles for article (PubMed ID: 30885933)
21.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
22. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
O'Brien S; Fothergill JL
FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
[TBL] [Abstract][Full Text] [Related]
23. Impact of D-amino acid dehydrogenase on virulence factor production by a Pseudomonas aeruginosa.
Oliver KE; Silo-Suh L
Can J Microbiol; 2013 Sep; 59(9):598-603. PubMed ID: 24011342
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
25. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
[TBL] [Abstract][Full Text] [Related]
26. Nitrite reductase is critical for Pseudomonas aeruginosa survival during co-infection with the oral commensal Streptococcus parasanguinis.
Scoffield JA; Wu H
Microbiology (Reading); 2016 Feb; 162(2):376-383. PubMed ID: 26673783
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa Proteome under Hypoxic Stress Conditions Mimicking the Cystic Fibrosis Lung.
Kamath KS; Krisp C; Chick J; Pascovici D; Gygi SP; Molloy MP
J Proteome Res; 2017 Oct; 16(10):3917-3928. PubMed ID: 28832155
[TBL] [Abstract][Full Text] [Related]
28. Staphylococcus aureus and Pseudomonas aeruginosa Isolates from the Same Cystic Fibrosis Respiratory Sample Coexist in Coculture.
Bernardy EE; Raghuram V; Goldberg JB
Microbiol Spectr; 2022 Aug; 10(4):e0097622. PubMed ID: 35867391
[TBL] [Abstract][Full Text] [Related]
29. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.
McDaniel MS; Schoeb T; Swords WE
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932329
[No Abstract] [Full Text] [Related]
30. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
31. Help, hinder, hide and harm: what can we learn from the interactions between
Limoli DH; Hoffman LR
Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898
[TBL] [Abstract][Full Text] [Related]
32. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication.
Duan K; Dammel C; Stein J; Rabin H; Surette MG
Mol Microbiol; 2003 Dec; 50(5):1477-91. PubMed ID: 14651632
[TBL] [Abstract][Full Text] [Related]
33. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
34. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability.
Filkins LM; Hampton TH; Gifford AH; Gross MJ; Hogan DA; Sogin ML; Morrison HG; Paster BJ; O'Toole GA
J Bacteriol; 2012 Sep; 194(17):4709-17. PubMed ID: 22753064
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.
Winstanley C; O'Brien S; Brockhurst MA
Trends Microbiol; 2016 May; 24(5):327-337. PubMed ID: 26946977
[TBL] [Abstract][Full Text] [Related]
37. A commensal streptococcus hijacks a Pseudomonas aeruginosa exopolysaccharide to promote biofilm formation.
Scoffield JA; Duan D; Zhu F; Wu H
PLoS Pathog; 2017 Apr; 13(4):e1006300. PubMed ID: 28448633
[TBL] [Abstract][Full Text] [Related]
38. Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.
Baldan R; Cigana C; Testa F; Bianconi I; De Simone M; Pellin D; Di Serio C; Bragonzi A; Cirillo DM
PLoS One; 2014; 9(3):e89614. PubMed ID: 24603807
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
40. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
